These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 30373494

  • 1. Adherence to Recommended Care Guidelines in the Treatment of Preschool-Age Medicaid-Enrolled Children With a Diagnosis of ADHD.
    Moran A, Serban N, Danielson ML, Grosse SD, Cuffe SP.
    Psychiatr Serv; 2019 Jan 01; 70(1):26-34. PubMed ID: 30373494
    [Abstract] [Full Text] [Related]

  • 2. Vital Signs: National and State-Specific Patterns of Attention Deficit/Hyperactivity Disorder Treatment Among Insured Children Aged 2-5 Years - United States, 2008-2014.
    Visser SN, Danielson ML, Wolraich ML, Fox MH, Grosse SD, Valle LA, Holbrook JR, Claussen AH, Peacock G.
    MMWR Morb Mortal Wkly Rep; 2016 May 06; 65(17):443-50. PubMed ID: 27149047
    [Abstract] [Full Text] [Related]

  • 3. Medicaid Prior Authorization Policies for Medication Treatment of Attention-Deficit/Hyperactivity Disorder in Young Children, United States, 2015.
    Hulkower RL, Kelley M, Cloud LK, Visser SN.
    Public Health Rep; 2017 May 06; 132(6):654-659. PubMed ID: 29072963
    [Abstract] [Full Text] [Related]

  • 4. Receipt of Medication and Behavioral Therapy Among a National Sample of School-Age Children Diagnosed With Attention-Deficit/Hyperactivity Disorder.
    Walls M, Allen CG, Cabral H, Kazis LE, Bair-Merritt M.
    Acad Pediatr; 2018 Apr 06; 18(3):256-265. PubMed ID: 29061327
    [Abstract] [Full Text] [Related]

  • 5. Treatment of Attention-Deficit/Hyperactivity Disorder in Preschool-Age Children: Child and Adolescent Psychiatrists' Adherence to Clinical Practice Guidelines.
    Chung J, Tchaconas A, Meryash D, Adesman A.
    J Child Adolesc Psychopharmacol; 2016 May 06; 26(4):335-43. PubMed ID: 27105063
    [Abstract] [Full Text] [Related]

  • 6. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
    Bussing R, Narwaney KJ, Winterstein AG, Newton DA, DeBar L, Boscarino JA, Toh S, Pawloski P, Nordin JD, Herrinton LJ, Mason D, Daley MF.
    Curr Med Res Opin; 2014 Aug 06; 30(8):1687-99. PubMed ID: 24635013
    [Abstract] [Full Text] [Related]

  • 7. A National Description of Treatment among United States Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
    Danielson ML, Visser SN, Chronis-Tuscano A, DuPaul GJ.
    J Pediatr; 2018 Jan 06; 192():240-246.e1. PubMed ID: 29132817
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Use of practice guidelines in the primary care of children with attention-deficit/hyperactivity disorder.
    Rushton JL, Fant KE, Clark SJ.
    Pediatrics; 2004 Jul 06; 114(1):e23-8. PubMed ID: 15231969
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mental Health Service Use by Medicaid-Enrolled Children and Adolescents in Primary Care Safety-Net Clinics.
    Cummings JR, Ji X, Druss BG.
    Psychiatr Serv; 2020 Apr 01; 71(4):328-336. PubMed ID: 31960778
    [Abstract] [Full Text] [Related]

  • 15. Ten-Year Trends In Treatment Services For Children With Attention Deficit Hyperactivity Disorder Enrolled In Medicaid.
    Hoagwood KE, Kelleher K, Zima BT, Perrin JM, Bilder S, Crystal S.
    Health Aff (Millwood); 2016 Jul 01; 35(7):1266-70. PubMed ID: 27385243
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Epidemiology of Treatment for Preschoolers on Kentucky Medicaid Diagnosed with Attention-Deficit/Hyperactivity Disorder.
    Davis DW, Feygin Y, Creel L, Kong M, Jawad K, Sun J, Blum NJ, Lohr WD, Williams PG, Le J, Jones VF, Pasquenza N.
    J Child Adolesc Psychopharmacol; 2020 Sep 01; 30(7):448-455. PubMed ID: 32614247
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.